Skip to main content

Closed

EVAX: Evaxion Biotech A/S Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+125.1% / yr

Operating margin-122.0%

ROIC-35.5%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-11.3×

Current ratio0.00×

Evaxion Biotech A/S

EVAXNASDAQ Capital Market·USD·Closed

Evaxion Biotech A/S

EVAXNASDAQ·USD·Closed

$2.82

−0.35%

$2.82

−$0.01 (0.35%)

52W Range

4thpctl

Volume

0.59×avg

Mkt Cap

17.81MUSD

P/E

-1.8TTM

Div Yield

–ann

52W Range

4thpctl

Volume

0.59×avg

Market Cap

17.81MUSD

P/E Ratio

-1.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings